Dr. David Chiu, MD

NPI: 1194892075
Total Payments
$108,375
2022 Payments
$6,957
Companies
2
Transactions
157

Payment Breakdown by Category

Other$92,050 (84.9%)
Travel$13,317 (12.3%)
Food & Beverage$3,008 (2.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $92,050 38 84.9%
Travel and Lodging $13,317 74 12.3%
Food and Beverage $3,008 45 2.8%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $108,349 156 $0 (2022)
GENZYME CORPORATION $26.24 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $6,957 4 PFIZER INC. ($6,957)
2021 $20,475 9 PFIZER INC. ($20,475)
2018 $34,618 65 PFIZER INC. ($34,618)
2017 $46,326 79 PFIZER INC. ($46,299)

All Payment Transactions

157 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/14/2022 Pfizer Inc. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/14/2022 Pfizer Inc. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/29/2022 PFIZER INC. Food and Beverage In-kind items and services $132.06 General
01/13/2022 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/07/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/16/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/09/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/27/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/27/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/27/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/07/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/24/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/22/2021 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,275.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/12/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $354.62 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/12/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $112.14 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/12/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $72.34 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/12/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $21.80 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/12/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $4.75 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/07/2018 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,750.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/06/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $29.67 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/28/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $556.05 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/27/2018 PFIZER INC. ELIQUIS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,750.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/22/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $96.60 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/22/2018 PFIZER INC. ELIQUIS (Drug) Travel and Lodging In-kind items and services $21.80 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/22/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $18.94 General
Category: CARDIOVASCULAR;METABOLIC DISEASE

About Dr. David Chiu, MD

Dr. David Chiu, MD is a Internal Medicine healthcare provider based in Bellflower, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194892075.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chiu, MD has received a total of $108,375 in payments from pharmaceutical and medical device companies, with $6,957 received in 2022. These payments were reported across 157 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($92,050).

Practice Information

  • Specialty Internal Medicine
  • Location Bellflower, CA
  • Active Since 11/29/2006
  • Last Updated 12/02/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1194892075

Products in Payments

  • ELIQUIS (Drug) $108,217
  • LUMIZYME (Drug) $26.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Bellflower